Clinical trial
Partially-blind (Observer-blind) Study of Safety and Immunogenicity of Two…
NCT00360230 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00360230 |
|---|---|
| Title | Partially-blind (Observer-blind) Study of Safety and Immunogenicity of Two Malaria Vaccines in Ghanaian Children |
| Official title | A Partially-blind (Observer-blind) Study to Evaluate the Safety and Immunogenicity of 3 Different Vaccination Schedules With 2 GSK Biologicals' Candidate Plasmodium Falciparum Vaccines in Children Aged 5 to 17 Months Living in Ghana |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Malaria |
| Intervention type | Biological |
| Interventions | GSK Biologicals' candidate Plasmodium falciparum malaria vaccine 257049, Rabipur |
| Enrollment | 540 |
| Start date | Aug 30, 2006 |
| Primary completion | Aug 25, 2007 |
| Completion | May 30, 2008 |
| First posted | Aug 4, 2006 |
| Last update posted | Feb 19, 2018 |
| Countries | Ghana |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: